To the Editor In their recent Viewpoint1 about regulation of health care prices, the authors claimed that instituting a price backstop for commercial insurance markets would limit the ability of consolidated health systems to exploit their growing market power. Although this approach has many virtues, as described, a flat backstop would serve as a blunt instrument for restraining prices.
Lusk JB, McDevitt RC. Backstop Price Caps in Commercial Health Care Markets. JAMA. 2021;326(3):276–277. doi:10.1001/jama.2021.6809
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: